MASCC clinical practice statement: Prevention and management of acute radiation dermatitis using topical corticosteroids
Supportive Care in Cancer · 2026-05 · 34 (5)
DOI: 10.1007/s00520-026-10659-1 ↗Kurz gefasst
Leitlinie in der Zeitschrift Supportive Care in Cancer, online erschienen am 13.04.2026. Verfasst von Henry C Y Wong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Princess Margaret Hospital, Kowloon West Cluster, Hospital Authority, 2-10 Princess Margaret Hospital Road, Lai Chi Kok, Kowl…. Hauptthemen laut MEDLINE: Radiodermatitis, Adrenal Cortex Hormones. Die Arbeit nennt 42 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: A MASCC Clinical Practice Statement (CPS) serves as a brief, practical, clinician-oriented tool that highlights essential information for managing complications from anti-cancer treatments in cancer patients. This CPS provides guidance on the use of topical corticosteroids (TC) in the prevention and management of acute radiation dermatitis (ARD). METHODS: This CPS was developed based on a critical evaluation of the literature identified through a search in MEDLINE till November 23, 2025, followed by a structured discussion of a group of experts of the MASCC Oncodermatology Study Group. The information is summarised in concise bullet points to create a brief manual on optimal standard care practices. RESULTS: Recommendations were provided regarding patient selection criteria for TC in the prevention and management of ARD. Guidance was also presented on the optimal choice of TC, its timing, schedule, application details, and monitoring of clinical effects to achieve the best outcomes based on existing literature. CONCLUSION: TCs are recommended for the prevention of ARD in selected patients with head and neck and breast cancers at a high risk of ARD. TC is also a treatment option for the management of patients with early ARD without evidence of moist desquamation. Medium potency TCs, such as mometasone furoate 0.1% cream, are preferred. Healthcare professionals should monitor patients' skin weekly during radiation and guide steroid use, discontinuing it if moist desquamation or other complications arise.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Princess Margaret Hospital, Kowloon West Cluster, Hospital Authority, 2-10 Princess Margaret Hospital Road, Lai Chi Kok, Kowloon, Hong Kong S.A.R, China. henrywong3011@gmail.com.
- Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore.
- Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Department of Radiation Oncology, University of Rochester, Rochester, NY, USA.
- Catharina Hospital, Eindhoven and Santeon, Utrecht, Netherlands.
- Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Adelaide, Australia.
Zitieren
APA
Wong, H. C. Y., Lee, S. F., Wolf, J. R., van den Hurk, C., Chan, R. J., Sauder, M., Kwan, J. Y. Y., Aquilano, M., Tse, S. S. W., Marta, G. N., Chow, E., & Bonomo, P. (2026). MASCC clinical practice statement: Prevention and management of acute radiation dermatitis using topical corticosteroids. Supportive Care in Cancer, 34(5). https://doi.org/10.1007/s00520-026-10659-1
Vancouver
Wong HCY, Lee SF, Wolf JR, van den Hurk C, Chan RJ, Sauder M, et al. MASCC clinical practice statement: Prevention and management of acute radiation dermatitis using topical corticosteroids. Supportive Care in Cancer. 2026;34(5). doi:10.1007/s00520-026-10659-1
BibTeX
@article{Wong2026,
author = {Wong, Henry C Y and Lee, Shing Fung and Wolf, Julie Ryan and van den Hurk, Corina and Chan, Raymond J and Sauder, Maxwell and Kwan, Jennifer Y Y and Aquilano, Michele and Tse, Shirley S W and Marta, Gustavo Nader and Chow, Edward and Bonomo, Pierluigi},
title = {MASCC clinical practice statement: Prevention and management of acute radiation dermatitis using topical corticosteroids},
journal = {Supportive Care in Cancer},
year = {2026},
volume = {34},
number = {5},
doi = {10.1007/s00520-026-10659-1}
}
EUVIMED